You are here

Merck

US drugmaker Merck to boost workforce in India

Economic Times, India

Wed, 02/26/25 - 11:18 am

Can Keytruda finally break into early head and neck cancer?

Pharmaphorum

Wed, 02/26/25 - 09:59 am

head and neck cancer

Merck expects Keytruda to face HHS price setting in 2026

MSN/Reuters

Tue, 02/25/25 - 10:45 pm

Inflation Reduction Act

Trump administration, pharma clash: 4 notes

Beckers Hospital Review

Mon, 02/24/25 - 04:54 pm

Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets

Fierce Biotech

Mon, 02/24/25 - 11:32 am

Teva Pharmaceutical

clinical trials

inflammatory bowel disease

FDA looks at Opdivo/Yervoy in first-line colorectal cancer

Pharmaphorum

Mon, 02/24/25 - 09:56 am

Bristol Myers Squibb

colorectal cancer

Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens

Fierce Biotech

Wed, 02/19/25 - 09:54 am

Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production

Pharma Voice

Wed, 02/19/25 - 09:44 am

drug manufacturing

Young Institute Pharmaceutical Manufacturing Consortium

Merck Vaccine Trial Delayed as RFK Jr. Link Creates Jury Concern

MSN/Bloomberg

Tue, 02/18/25 - 11:08 pm

Robert F Kennedy Jr.

Gilead loses interest in Arcus' kidney cancer rival to Merck's Welireg

Fierce Biotech

Tue, 02/18/25 - 11:02 pm

Arcus Biosciences

Gilead Sciences

Merck Is Embracing AI, But ‘We Always Have a Human in the Loop,’ Exec Says

MedCity News

Tue, 02/18/25 - 09:43 am

artificial intelligence

Pending US Vaccine Decisions as Kennedy Takes Top Health Job

US News and World Report

Fri, 02/14/25 - 09:25 am

Robert F Kennedy Jr.

Bavarian Nordic

In the crowded cardio space, it’s David vs. Goliath for small biotechs

Pharma Voice

Tue, 02/11/25 - 11:12 am

cardiovascular disease

Kineta sells Genentech and Merck deals to investor ahead of TuHURA merger

Fierce Biotech

Mon, 02/10/25 - 10:19 am

TuHURA Biosciences

Pacira Pharmaceuticals

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

Pharma Voice

Fri, 02/7/25 - 11:16 am

Merck commences Phase III trial of DLBCL treatment

Clinical Trials Arena

Fri, 02/7/25 - 11:14 am

clinical trials

zilovertamab vedotin

Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China

CNBC

Tue, 02/4/25 - 09:36 am

Lawmakers urge RFK Jr. to answer to Gardasil litigation conflict-of-interest concerns ahead of confirmation vote

Fierce Pharma

Mon, 02/3/25 - 07:07 pm

Robert F Kennedy Jr.

With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair

Fierce Pharma

Thu, 01/30/25 - 10:58 am

clinical trials

After slow rollout, Merck's Winrevair poised for 'strong uptake' in 2025: Leerink

Fierce Pharma

Sun, 01/26/25 - 04:09 pm

Pages